This bill requires New York's health department to create and operate a free mobile application for individuals eligible for Medicaid who are pregnant, postpartum, or planning pregnancy. The app must provide New York-specific resources, links to state programs, and support in multiple languages, with strict privacy protections prohibiting personal data sharing. Developers must report anonymized usage data (like user numbers and engagement) to state lawmakers. The app will be available across mobile platforms and must comply with state health resource standards.
Provides that the commissioner of education may promulgate rules and regulations for a health education curriculum to include menstrual disorders, including but not limited to, endometriosis.
Requires certain health insurance issuers to certify that at least a majority of prescription drug rebates are provided to patients at the point of sale.
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Requires that services at addiction treatment centers operated by the office of addiction services and supports shall not be refused at such centers if a person is unable to pay.
Creates a wholesale prescription drug importation program which complies with federal standards and regulations for the purpose of generating substantial savings for consumers.
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Establishes a quality incentive program for managed care providers that is distributed based on managed care providers' performance in meeting quality objectives.
This bill (S 8756) modifies the implementation timeline for a law allowing close friends to arrange body donations for medical purposes after a person's death. It changes the effective date so that the health commissioner can immediately begin implementing the law - rather than waiting 180 days - upon the bill's passage. This adjustment primarily affects individuals who wish to donate a deceased person's body for medical education or research, ensuring faster administrative readiness. The bill is procedural in nature, focusing solely on implementation timing, not the eligibility for body donations.
This bill requires insurers and health care plans to follow specific rules when using virtual credit cards or fee-based digital payment methods to reimburse healthcare providers. Insurers must first notify providers of any potential fees, offer a fee-free payment alternative, and get the provider's written consent within 30 days to use the fee-based method. If a provider doesn't respond in time, insurers must default to the fee-free option. The law applies directly to insurers and healthcare providers who contract with them, ensuring transparency and preventing unexpected charges for providers.
